An Insight into Anticancer Bioactives from (Pomegranate).

Anticancer Agents Med Chem

Department of Pharmacy, Banasthali Vidyapith, Banasthali, Rajasthan-304022, India.

Published: April 2022


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Cancer is one of the major reasons for mortality across the globe. Many side-effects are associated with the formulations available in the market, affecting the quality of life of the patients. This has caused the researchers to find an alternative source of medications, such as herbal medicine, showing a promising effect in anticancer treatment; one such source is Pomegranate, which belongs to the family Punicaceae. Punica granatum contains many polyphenols that have antioxidant, antidiabetic, and therapeutic effects in the treatment and management of metabolic and cardiovascular diseases, as well as a favourable effect on anticancer therapy. Polyphenols like punicalin, punicalagin, and ellagic acid are a few of the many compounds responsible for the anticancer activity of pomegranate. Many preparations of pomegranate, such as Pomegranate Juice (PJ), Pomegranate Seed Oil (PSO), Pomegranate peel extract (PoPx), etc. are used in various clinical studies. These polyphenols show anticancer activity by either arresting the cell cycle in the G2/M phase, inducing apoptosis or damaging the DNA of tumor cells. This review explicitly discusses the role and mechanism of bioactives obtained from the pomegranate in the treatment and management of cancer. The chemical structure, properties, and role of pomegranate in the treatment of breast, lung, thyroid, colon, and prostate cancer have been focused on in detail. This review also discusses various targeted drug delivery approaches for tumour treatment as well as patented preparation of pomegranate compounds along with the ongoing clinical trials.

Download full-text PDF

Source
http://dx.doi.org/10.2174/1871520621666210726143553DOI Listing

Publication Analysis

Top Keywords

pomegranate
10
bioactives pomegranate
8
treatment management
8
anticancer activity
8
pomegranate treatment
8
treatment
5
insight anticancer
4
anticancer bioactives
4
pomegranate cancer
4
cancer major
4

Similar Publications

Exploring potential protein-protein interactions driving unusual fatty acid synthesis in pomegranate.

Plant Physiol Biochem

September 2025

Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alberta, T6G 2P5, Canada. Electronic address:

Many plant-derived unusual fatty acids (UFAs) possess valuable chemical properties and have potential applications in the food, feed, and oleochemical industries. Despite significant interest, the mechanisms by which plants synthesize and accumulate these structurally distinct fatty acids remain only partially understood. While enzyme substrate specificities involved in UFA-containing storage lipid assembly have been well characterized in many prior studies, the biochemical roles of protein-protein interactions (PPIs) in coordinating UFA biosynthesis have received less attention.

View Article and Find Full Text PDF

Ellagic acid (EA), a bioactive polyphenol abundant in pomegranate and berries, exhibits potential in metabolic regulation. This study investigates EA's anti-obesity mechanisms, focusing on its effects on gut microbiota and transcriptional regulation in adipose tissue. After a 9-week high-fat diet feeding, mice were divided into groups and treated with low-dose EA (10 mg/kg/day), high-dose EA (30 mg/kg/day), or urolithin A (20 mg/kg/day) for 7 weeks, with healthy and obese controls included.

View Article and Find Full Text PDF

Pomegranate processing generates large quantities of pomace and mesocarp, yet their carbohydrate composition remains largely unexplored. Here, we applied comprehensive mass spectrometry-based profiling to characterize monosaccharides, oligosaccharides, and polysaccharides from these side streams. Fructose and glucose dominated the free sugar fraction in both tissues.

View Article and Find Full Text PDF

The effects of the phenolic compounds punicalagin and ellagic acid, derived from pomegranate, were analyzed on the gene expression of cultured human fibroblasts. The focus was placed on genes associated with growth factors, differentiation markers, and extracellular matrix (ECM) components, all of which play a crucial role in effective wound healing. The human dermal fibroblast cell line CCD-1064Sk was used, and the bioactive compounds punicalagin and ellagic acid were administered to cultured fibroblasts at concentrations of 10 and 10 M, respectively.

View Article and Find Full Text PDF

Background:  Sepsis disrupts normal wound healing and causes organ damage through a systemic inflammatory response. Pomegranate () is a natural antioxidant rich in polyphenols, such as ellagitannins and punicalagins, and has demonstrated potential anti-inflammatory and tissue-healing properties in various preclinical models.

Objective:  This study aimed to evaluate the effects of pomegranate extract administered before and after sepsis induction on wound healing in a cecal ligation and puncture (CLP) rat model.

View Article and Find Full Text PDF